基金经理：过蓓蓓
| 单位净值:1.3741 | 净值增长率:-1.53% | 净值增长率:-1.53% | 累计净值:1.3741 | 截止日期:2026/6/5 | |
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:0.01亿元 | 风险等级:高风险 | 申购状态:可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇(017951)资产配置 |
|||||
|---|---|---|---|---|---|
| 报告日期 | 股票(元) | 债券(元) | 基金总资产(元) | 基金净值(元) | 股票占净值比 |
| 2026/3/31 | 0 | 506,637 | 439,291,000 | 433,260,000 | 0% |
| 2025/12/31 | 0 | 1,111,740 | 470,167,000 | 459,146,000 | 0% |
| 2025/9/30 | 0 | 2,933,220 | 419,487,000 | 411,683,000 | 0% |
| 2025/6/30 | 0 | 2,923,280 | 380,666,000 | 369,594,000 | 0% |
| 2025/3/31 | 0 | 2,310,020 | 236,267,000 | 233,376,000 | 0% |
| 2024/12/31 | 0 | 2,310,070 | 314,024,000 | 310,278,000 | 0% |
| 2024/9/30 | 0 | - | 262,435,000 | 252,678,000 | 0% |
| 2024/6/30 | 0 | - | 228,652,000 | 215,860,000 | 0% |
| 2024/3/31 | 0 | - | 280,519,000 | 273,987,000 | 0% |
| 2023/12/31 | 0 | 904,710 | 197,568,000 | 194,383,000 | 0% |
| 2023/9/30 | 0 | - | 76,342,400 | 74,581,200 | 0% |
| 2023/6/30 | 0 | - | 40,311,500 | 39,439,300 | 0% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。